Poseida Therapeutics | IPO Presentation Deck | 34 slides · page 24 of 34
The slide uses a quadrant key to identify T-cell subsets (Teff, TSCM, Tem, Tcm) and highlights the persistence of TSCM cells post-tumor elimination.
Pitch deck · traction · show_traction · balanced density
Slide locked Sign in to view
Slide schematic 5/5
callout 1/1 chart 1/1 diagram 1/1 source-note 1/1 title 1/1
Components 5
primary scatter legend source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1